Loading...

OTC Markets

Totals

Securities

12,279

Dollar Vol

$2.5B

Share Vol

4.9B

Trades

398,723

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

Market Activity
Stock
CSLLY
Company Profile

CSLLY
CSL Ltd.

57.62

-0.96

-1.64%

57.62 / 57.94 (800 x 100)

Real-Time Best Bid & Ask: 05:00pm 10/31/2025

Delayed (15 Min) Trade Data: 12:00am 10/31/2025

CSL Ltd.

655 Elizabeth Street

Melbourne, VA 3000

Australia

Principal Executive Offices:

655 Elizabeth Street

Melbourne, VIC 3000

Australia

www.csl.com.au

+61 3-9389-1911

InvestorRelations@csl.com.au

Business Description

CSL is a leading global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology.

Financial Reporting

Reporting Status

International Reporting: ASX - Australian Securities Exchange

Audited Financials

Audited

CIK

0001274152

Fiscal Year End

6/30

Company Officers & Contacts

Paul McKenzie

CEO

Joy Linton

CFO

Accounts Payable - CSL

Accountant

Chris Cooper

Head of IR

Fiona Mead

Company Secretary

Board of Directors

Brian McNamee

Chairman, Independent Director, Nominating Committee Member

Megan Clark

Independent Director, Nominating Committee Member

Andrew Cuthbertson

Nominating Committee Member

Carolyn Hewson

Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member

Duncan Maskell

Independent Director

Marie McDonald

Independent Director, Audit Committee Member, Compensation Committee Member

Alison Watkins

Independent Director, Audit Committee Member, Compensation Committee Member

Other Company Insiders

Unknown Unknown

HSBC CUSTODY NOMINEES (AUSTRALIA) LIMITED

Beneficial Owner Unknown

J P MORGAN NOMINEES AUSTRALIA PTY LIMITED

Beneficial Owner Unknown

HSBC CUSTODY NOMINEES (AUSTRALIA) LIMITED

Other Company Insiders are all persons or entities beneficially owning 10% or more of any class of the issuer's securities. Together, officers, directors and other company insiders comprise Company Insiders.

Service Providers

Accounting/Auditing Firm

Deloitte Touche Tohmatsu

550 Bourke Street

Melbourne, VA 3000

Australia

Securities Counsel

Allens Linklaters

Level 37

101 Collins Street

Melbourne, VA 3000

Australia

Profile Data

Joined OTCQX

04/2023

SIC - Industry Classification

2834 - Pharmaceutical preparations

Incorporation Information

VA, AU, 1991

Employees

29,000 as of 06/30/2025

Shell

Products and Services

Today, CSL – including our three businesses, CSL Behring, CSL Seqirus and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 29,000 people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest.

Company Facilities

7 manufacturing sites across six countries - Bern, Switzerland - Broadmeadows, Australia - Marburg, Germany - Kankakee, United States - Liverpool, United Kingdom - Holly Springs, United States - Parkville, Australia

Company Notes

Sponsored for OTCQX International by BNY Mellon on April 26th, 2023.